These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

957 related items for PubMed ID: 17760691

  • 1. Clostridium botulinum type A toxin for the treatment of upper face animation lines: an Iranian experience.
    Farahvash MR, Arad S.
    J Cosmet Dermatol; 2007 Sep; 6(3):152-8. PubMed ID: 17760691
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 Sep; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 5. [Botulinum toxin A in the treatment of the wrinkles in the upper third of the face].
    Gassia V.
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 3():S175-80. PubMed ID: 18342124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum toxin A for the treatment of lateral periorbital rhytids.
    Kim DW, Cundiff J, Toriumi DM.
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):445-51. PubMed ID: 15062248
    [Abstract] [Full Text] [Related]

  • 8. Comparing two types of botulinum-A toxin detrusor injections in patients with severe neurogenic detrusor overactivity: a case-control study.
    Grosse J, Kramer G, Jakse G.
    BJU Int; 2009 Sep; 104(5):651-6. PubMed ID: 19281462
    [Abstract] [Full Text] [Related]

  • 9. New indications for botulinum toxin type A in treating facial wrinkles of the mouth and neck.
    Spósito MM.
    Aesthetic Plast Surg; 2002 Sep; 26(2):89-98. PubMed ID: 12016492
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A pilot study on the effect of epinephrine on botulinum toxin treatment for periorbital rhytides.
    Hantash BM, Gladstone HB.
    Dermatol Surg; 2007 Apr; 33(4):461-8. PubMed ID: 17430381
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC.
    Am J Clin Dermatol; 2010 Apr; 11(3):183-99. PubMed ID: 20369902
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: double-blind, placebo-controlled, dose-ranging study.
    Ascher B, Rzany BJ, Grover R.
    Dermatol Surg; 2009 Oct; 35(10):1478-86. PubMed ID: 19686365
    [Abstract] [Full Text] [Related]

  • 15. Botulinum toxin. The Newport Beach experience.
    Fulton JE.
    Dermatol Surg; 1998 Nov; 24(11):1219-24. PubMed ID: 9834742
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.